ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1646

Prevalence of Spondyloarthritis in Patients with Anterior Uveitis

Kristyna Bubova1,2, Monika Gregová1,2, Katerina Zegzulkova1,2, Karel Pavelka1,2, Jarmila Heissigerova3,4 and Ladislav Šenolt2,5, 1Department of Rheumatology, First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, 2Institute of Rheumatology, Prague, Czech Republic, Prague, Czech Republic, 3Department of Ophthalmology, First Faculty of Medicine, Charles University, Prague Czech Republic, Prague, Czech Republic, 4Department of Ophthalmology, General University Hospital in Prague, Prague, Czech Republic, Prague, Czech Republic, 5First Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: bone marrow lesions, Magnetic resonance imaging (MRI), spondylarthritis and uveitis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, October 22, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster II: Clinical/Epidemiology Studies

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Anterior uveitis (AU) is a common extraarticular manifestation in spondyloarthritis (SpA). The disease can precede the typical axial and peripheral features. Additionally, some studies had described the imaging signs of sacroiliac involvement in patients with AU lacking chronic back pain. The aim of this study was to examine patients with AU, to determine whether the patients already fulfil criteria for axial and/or peripheral SpA and to stratify risk factors for SpA development.

Methods:

We recruited 41 patients without prior rheumatologic diagnosis who developed at least one episode of AU. The clinical data were collected and rheumatology examinations were performed by trained rheumatologists. Magnetic resonance imaging (MRI) of sacroiliac joints (SIJ) was read by trained rheumatologist who was blinded to the patient data. Patients were further divided into SpA subsets (axial: imaging and clinical arm and peripheral SpA) fulfilling The Assessment of SpondyloArthritis international Society (ASAS) classification criteria1 and non-SpA subset. The ASAS modified Berlin algorithm for diagnosis of axial SpA2 (axSpA) was also applied.

Results: Altogether, 22.0% (n=9) patients referred inflammatory back pain, 48.8% (n=20) referred non-inflammatory back pain and 29.3% (n=12) did not refer back pain. Bone marrow edema (BME) was found in 48.8% (n=20) of all patients with AU, however 31.7% (n=13) had highly suggestive BME3 corresponding to typical findings in sacroiliitis. The diagnosis of SpA was confirmed in 41.5% (n=17) of all patients with AU, 26.8% (n=11) patients fulfil the imaging arm and 12.2% (n=5) fulfil the clinical arm of ASAS classification criteria for axSpA, 4.9% (n=2) patients fulfil ASAS classification criteria for peripheral SpA (one patient fulfil both axial and peripheral criteria). Two patients lacking back pain developed highly suggestive BME on SIJ. The diagnosis of axSpA according to the Ankylosing Spondylitis Disease Activity Score (ASDAS) modified berlin algorithm was confirmed in 41.5% (n=17) patients. Analysis of clinical characteristics showed significant difference between ASDAS in SpA vs. non-SpA (1.6 ±0.7 vs 0.8 ±0.6, p<0.001, respectively), and remained significant in axSpA and also in those fulfilling only imaging arm of axial SpA (i-axSpA) (p=0.002, p=0.016, respectively). The levels of CRP were significantly higher in SpA and axSpA compared to non-SpA subsets (9.5 ±10.3, 8.7 ±10.1 vs. 2.2 ±2.2 mg/L, p=0.005, p=0.009, respectively). Presence of back pain and inflammatory back pain were more often in SpA compared to non-SpA subsets (94.1% and 47.1% vs. 54.2% and 4.2%, p=0.006 and p=0.002 respectively).

Conclusion:

More than one third of patients with anterior uveitis fulfilled the criteria for axial or peripheral SpA. Furthermore, these patients had significantly higher presence of back pain, increased ASDAS and serum CRP levels. Inflammatory back pain was significantly more often in patients classified as axSpA.

Acknowledgement:

Supported by MH CR 023728, SVV 260373, AZV – 17-33127A


Disclosure: K. Bubova, None; M. Gregová, None; K. Zegzulkova, None; K. Pavelka, None; J. Heissigerova, None; L. Šenolt, None.

To cite this abstract in AMA style:

Bubova K, Gregová M, Zegzulkova K, Pavelka K, Heissigerova J, Šenolt L. Prevalence of Spondyloarthritis in Patients with Anterior Uveitis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/prevalence-of-spondyloarthritis-in-patients-with-anterior-uveitis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-of-spondyloarthritis-in-patients-with-anterior-uveitis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology